Macrophage-Targeted Spermine Nanodelivery Attenuates AECOPD-Associated Lung Inflammation Associated with ZFP36 Upregulation and Reduced Inflammasome-Related Signaling

Background: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD), frequently triggered by Streptococcus pneumoniae, are major contributors to disease progression and mortality. Although the polyamine spermine exhibits anti-inflammatory properties, its mechanistic role in AECOPD and the limitations imposed by impaired cellular transport remain poorly defined. Methods: We established in vivo AECOPD mouse models and in vitro alveolar macrophage systems. Integrated metabolomics and proteomics analyses were performed to identify key regulatory pathways. Molecular experiments, including ZFP36 knockdown and pyroptosis-associated protein analyses, were performed to investigate the role of ZFP36 in spermine-mediated inflammatory regulation. To overcome impaired transporter-dependent uptake, a macrophage-targeted nanodelivery system (MSNs/HA-Man) was engineered, and its therapeutic efficacy was evaluated in vivo. Results: Spermine levels were significantly reduced in COPD and AECOPD. Mechanistically, spermine treatment was associated with increased ZFP36 expression and reduced activation of the NLRP3/Caspase-1/IL-1β pyroptosis pathway. Importantly, metabolomic pathway enrichment suggested that SLC-mediated transport may be altered under pathological conditions, raising the possibility that cellular uptake of spermine could be affected. The enhanced therapeutic efficacy of the engineered MSNs/HA-Man nanocarrier may be partly attributable to CD44/CD206-mediated endocytosis, which could reduce dependence on transporter-mediated uptake and improve intracellular delivery compared with free spermine. Conclusions: Our findings suggest that the spermine–ZFP36 axis may represent an important regulatory pathway associated with inflammation in AECOPD. Moreover, macrophage-targeted nanodelivery may improve intracellular delivery efficiency and therapeutic efficacy. This study provides a novel framework integrating metabolic modulation with proof-of-concept nanomedicine strategy for the treatment of COPD exacerbations.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2026-11-20
DOI
https://doi.org/10.3390/pharmaceutics18111500
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Macrophage-Targeted Spermine Nanodelivery Attenuates AECOPD-Associated Lung Inflammation Associated with ZFP36 Upregulation and Reduced Inflammasome-Related Signaling

程婷婷, Yun Feng, Jingya Yang, Xiaoyan Hu et al.
5 links
Pharmaceutics
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Macrophage-Targeted Spermine Nanodelivery Attenuates AECOPD-Associated Lung Inflammation Associated with ZFP36 Upregulation and Reduced Inflammasome-Related Signaling

程婷婷, Yun Feng, Jingya Yang, Xiaoyan Hu, HongChen Xiao, YiFan Lu, Fei Wang, Aoxiang Li, Ruonan Ni
article en

Abstract

Background: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD), frequently triggered by Streptococcus pneumoniae, are major contributors to disease progression and mortality. Although the polyamine spermine exhibits anti-inflammatory properties, its mechanistic role in AECOPD and the limitations imposed by impaired cellular transport remain poorly defined. Methods: We established in vivo AECOPD mouse models and in vitro alveolar macrophage systems. Integrated metabolomics and proteomics analyses were performed to identify key regulatory pathways. Molecular experiments, including ZFP36 knockdown and pyroptosis-associated protein analyses, were performed to investigate the role of ZFP36 in spermine-mediated inflammatory regulation. To overcome impaired transporter-dependent uptake, a macrophage-targeted nanodelivery system (MSNs/HA-Man) was engineered, and its therapeutic efficacy was evaluated in vivo. Results: Spermine levels were significantly reduced in COPD and AECOPD. Mechanistically, spermine treatment was associated with increased ZFP36 expression and reduced activation of the NLRP3/Caspase-1/IL-1β pyroptosis pathway. Importantly, metabolomic pathway enrichment suggested that SLC-mediated transport may be altered under pathological conditions, raising the possibility that cellular uptake of spermine could be affected. The enhanced therapeutic efficacy of the engineered MSNs/HA-Man nanocarrier may be partly attributable to CD44/CD206-mediated endocytosis, which could reduce dependence on transporter-mediated uptake and improve intracellular delivery compared with free spermine. Conclusions: Our findings suggest that the spermine–ZFP36 axis may represent an important regulatory pathway associated with inflammation in AECOPD. Moreover, macrophage-targeted nanodelivery may improve intracellular delivery efficiency and therapeutic efficacy. This study provides a novel framework integrating metabolic modulation with proof-of-concept nanomedicine strategy for the treatment of COPD exacerbations.

PharmaceuticsVol. 18(11)
Tongji University (CN), Shanghai Jiao Tong University (CN), Ruijin Hospital (CN), Shanghai East Hospital (CN), Shanghai Ocean University (CN)
National Natural Science Foundation of China
Good health and well-being
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon